back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-07-08 16:06 Tx date 2022-07-05 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
47 - Acquisition or disposition by gift
|
-600,000 vol |
1,154,500 | |
| Filed 2022-06-24 16:47 Tx date 2022-06-23 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
OTC Calls (including Private Options to Purchase) 250,000 common shares expires June 2022
73 - Expiration of third party derivative
|
+1 vol |
0 | |
| Filed 2021-12-14 17:52 Tx date 2021-12-09 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,166,750
+325,000 vol $3.59 each |
325,000 | |
| Filed 2021-12-14 17:49 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-14 20:25 Tx date 2021-09-10 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
47 - Acquisition or disposition by gift
|
-200,000 vol |
1,754,500 | |
| Filed 2021-05-25 17:06 Tx date 2021-05-25 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
47 - Acquisition or disposition by gift
|
$-48,000
-15,000 vol $3.20 each |
1,954,500 | |
| Filed 2021-02-10 20:09 Tx date 2021-02-10 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
47 - Acquisition or disposition by gift
|
$-190,001.50
-58,462 vol $3.25 each |
1,969,500 | |
| Filed 2021-02-10 20:06 Tx date 2021-02-10 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
54 - Exercise of warrants
|
$190,001
+58,462 vol $3.25 each |
2,027,962 | |
| Filed 2021-02-10 20:03 Tx date 2021-02-10 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-190,001.50
-58,462 vol $3.25 each |
0 | |
| Filed 2021-02-10 19:57 Tx date 2021-02-05 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
47 - Acquisition or disposition by gift
|
$-199,998.50
-61,538 vol $3.25 each |
1,969,500 | |
| Filed 2021-02-10 19:53 Tx date 2021-02-05 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
54 - Exercise of warrants
|
$199,998
+61,538 vol $3.25 each |
2,031,038 | |
| Filed 2021-02-10 19:47 Tx date 2021-02-05 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-199,998.50
-61,538 vol $3.25 each |
58,462 | |
| Filed 2020-08-20 18:02 Tx date 2020-08-20 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
47 - Acquisition or disposition by gift
|
-990,000 vol |
1,969,500 | |
| Filed 2020-06-29 17:08 Tx date 2020-06-28 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
OTC Calls (including Private Options to Purchase) 250,000 common shares expires June 2022
70 - Acquisition or disposition (writing) of third party derivative
|
$-10.00
-1 vol $10.00 each |
-1 | |
| Filed 2020-06-29 16:01 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
OTC Calls (including Private Options to Purchase) 250,000 common shares expires June 2022
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-06-05 15:58 Tx date 2020-06-04 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$26,400
+120,000 vol $0.22 each |
120,000 | |
| Filed 2020-06-05 15:55 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-06-05 15:48 Tx date 2020-06-04 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
15 - Acquisition or disposition under a prospectus
|
$573,600
+240,000 vol $2.39 each |
2,959,500 | |
| Filed 2019-10-16 15:24 Tx date 2019-10-15 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$2,880
+1,000 vol $2.88 each |
2,719,500 | |
| Filed 2019-10-16 15:23 Tx date 2019-10-15 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$5,529
+1,900 vol $2.91 each |
2,718,500 | |
| Filed 2019-10-16 15:22 Tx date 2019-10-15 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$287.00
+100 vol $2.87 each |
2,716,600 | |
| Filed 2019-10-16 15:22 Tx date 2019-10-15 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$1,360
+500 vol $2.72 each |
2,716,500 | |
| Filed 2019-10-16 15:21 Tx date 2019-10-15 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$1,370
+500 vol $2.74 each |
2,716,000 | |
| Filed 2019-10-16 15:20 Tx date 2019-10-15 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$2,750
+1,000 vol $2.75 each |
2,715,500 | |
| Filed 2019-10-16 15:19 Tx date 2019-10-15 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$5,700
+2,000 vol $2.85 each |
2,714,500 | |
| Filed 2019-10-16 15:18 Tx date 2019-10-15 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$7,300
+2,500 vol $2.92 each |
2,712,500 | |
| Filed 2019-10-15 17:06 Tx date 2019-10-11 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$468.00
+200 vol $2.34 each |
2,710,000 | |
| Filed 2019-10-15 17:05 Tx date 2019-10-11 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$1,764
+700 vol $2.52 each |
2,709,800 | |
| Filed 2019-10-15 17:05 Tx date 2019-10-11 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$520.00
+200 vol $2.60 each |
2,709,100 | |
| Filed 2019-10-15 17:04 Tx date 2019-10-11 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$259.00
+100 vol $2.59 each |
2,708,900 | |
| Filed 2019-10-15 17:04 Tx date 2019-10-11 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$4,626
+1,800 vol $2.57 each |
2,708,800 | |
| Filed 2019-10-15 17:03 Tx date 2019-10-11 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$5,566
+2,200 vol $2.53 each |
2,707,000 | |
| Filed 2019-10-15 16:39 Tx date 2019-10-11 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$11,376
+4,800 vol $2.37 each |
2,704,800 | |
| Filed 2019-02-22 Tx date 2019-02-20 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
47 - Acquisition or disposition by gift
|
-300,000 vol |
2,700,000 | |
| Filed 2018-12-21 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
3,000,000 |